From: www.ecancer.tv on Mon, Apr 19 2010 1:32 PM

Professor Cornelius Punt, chair of the Dutch Colorectal Cancer Group, discusses the multi discipline approach used by the DCCG in their work and plans for future collaborations with other groups within Europe. Prof. Punt goes on to describe the exciting new results in their SCRIPT clinical trial...

From: www.ecancer.tv on Fri, Apr 16 2010 9:24 AM

Professro Volker Diehl, of the University of Cologne, Germany, talks to ecancer managing editor Prof Gordon McVie at the 2010 German Cancer Conference (DKK), about personalised therapy for Hodgkin’s lymphoma and the latest from his 30 year old Hodgkin's lymphoma study group. He suggests red...

From: www.ecancer.tv on Thu, Apr 15 2010 11:39 AM

Although we can be optimistic thanks to the great advances that have been made in the field, there are still unacceptable levels of variation, with high cancer rates found in certain countries and socio-economic groups and a disparity in between the opinions of patients and doctors of what shoul...

From: www.ecancer.tv on Tue, Mar 30 2010 6:08 PM

Prof. Cornelia Ulrich, from the German National Center for tumour Diseases, discusses the start-up of a Division of Preventative Oncology in Heidelberg, Germany, which will look at prognosis factors such as diet.

From: www.ecancer.tv on Tue, Mar 30 2010 6:08 PM

Dr. Werner Hohenberger talks about the involvement of the German Cancer Society in developing a national cancer plan for Germany. The plan looks to implement measures that result in a high quality of cancer care throughout the whole of the country.

From: www.ecancer.tv on Tue, Mar 30 2010 6:08 PM

Dr. Manfred Wirth talks to ecancer.tv about the role of the urology group within the German Cancer Society. The roles of the group include organising trials, developing urology cancer centres and performing quality control

From: www.ecancer.tv on Tue, Mar 30 2010 6:08 PM

Prof. Otmar Wiestler talks about the work of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ). It is the largest biomedical research institute in Germany, which runs a number of research programmes including genome research, cancer risk factors, infection in cancer and ...

From: www.ecancer.tv on Tue, Mar 30 2010 7:28 AM

Dr Florian Lordick discusses the results of a multinational trial performed in Europe and Asia, which sampled 4,000 tumour probes, looking at the expression rates of HER2 in gastric cancer.

From: www.ecancer.tv on Tue, Mar 30 2010 7:28 AM

Dr Johannes Bruns from the German Cancer Society talks about the different aspects of the German Cancer Congress. He talks about its role in helping to educate young doctors in Germany about oncology and about it acting as a platform for the discussion of new scientific ideas.

From: www.ecancer.tv on Tue, Mar 30 2010 5:48 AM

Dr Bernd Groner, speaking at the 29th German Cancer Congress, discusses his work of looking at the relationship between stem cells in normal tissue and those in cancerous tissue through transplantation experiments with mice.

From: www.ecancer.tv on Thu, Mar 25 2010 7:59 AM

Presented at the 10th Milan Breast Cancer Conference

From: www.ecancer.tv on Thu, Mar 25 2010 7:59 AM

Presented at the 10th Milan Breast Cancer Conference

From: www.ecancer.tv on Thu, Mar 25 2010 7:59 AM

Eliot randomized trial. Presented at the 10th Milan Breast Cancer Conference.

From: www.ecancer.tv on Thu, Mar 25 2010 7:59 AM

10th Milan Breast Cancer Conference

From: www.ecancer.tv on Thu, Mar 25 2010 7:59 AM

Presented at the 10th Milan Breast Cancer Conference

From: www.ecancer.tv on Thu, Mar 25 2010 6:15 AM

10th Milan Breast Cancer Conference, Thursday, June 19, 2008. Antiangiogenic and metronomic chemotherapy: an approach to reducing the disparity between preclinical and clinical results.

From: www.ecancer.tv on Tue, Mar 02 2010 11:29 PM

Experts in haematology-oncology discuss the latest developments in multiple myeloma therapy, including highlights from ASH 2009. The discussion focuses on the evolving role of novel agents in the treatment of multiple myeloma, and how this translates to clinicians practice. Supported by an unres...

From: www.ecancer.tv on Mon, Mar 01 2010 3:56 PM

Prof Palumbo discusses the two papers he presented at ASH. The first, bortezomib, melphalan, prednisone and thalidomide followed by maintenance with bortezomib and thalidomide for initial treatment of elderly multiple myeloma patients. The second, a Phase III study to determine the efic...

From: www.ecancer.tv on Mon, Mar 01 2010 3:49 PM

Prof San- Miguel discusses the Phase IB, Multi-Center, Open-Label Dose-Escalation Study of Oral Panobinostat (LBH589) and I.V. Bortezomib in Patients with Relapsed Multiple Myeloma.

From: www.ecancer.tv on Mon, Mar 01 2010 3:41 PM

Dr Shaji Kumar discusses the improvement in treatment of multiple myeloma with new novel agents, specifically bortezomib and lenalidomide.